Table 1.
The association of miR-96-5p expression with the clinicopathological features of patients with HCC
| Features | Patients | miR-96-5p expression | P value | |
|---|---|---|---|---|
|
| ||||
| Low (n = 23) | High (n = 28) | |||
| Age (years) | ||||
| < 60 | 19 | 6 | 13 | 0.135 |
| ≥ 60 | 32 | 17 | 15 | |
| Sex | ||||
| Male | 38 | 15 | 23 | 0.168 |
| Female | 13 | 8 | 5 | |
| Tumor size | ||||
| < 5 cm | 25 | 10 | 15 | 0.473 |
| ≥ 5 cm | 26 | 13 | 13 | |
| TNM stage | ||||
| I-II | 27 | 7 | 20 | 0.004 |
| III-IV | 24 | 16 | 8 | |
| Differentiation | ||||
| Well/Moderately | 30 | 16 | 14 | 0.158 |
| Poorly | 21 | 7 | 14 | |
| Microvascular invasion | ||||
| Absent | 35 | 20 | 15 | 0.015 |
| Present | 16 | 3 | 13 | |
| Alcoholism | ||||
| No | 23 | 11 | 12 | 0.723 |
| Yes | 28 | 12 | 16 | |
| Cirrhosis | ||||
| Without | 17 | 8 | 9 | 0.842 |
| With | 34 | 15 | 19 | |
| HBsAg status | ||||
| Negative | 8 | 2 | 6 | 0.269 |
| Positive | 43 | 21 | 22 | |
HCC, hepatocellular carcinoma; HBsAg, hepatitis B surface antigen.